The San Diego-based startup gained FDA approval for its Hotwire RF guidewire in 2024. The technology has already been used to perform hundreds of heart procedures.

The investigational agent uses 60% less gadolinium without sacrificing image quality, according to recent clinical trial findings.

According to new data, the simulated virtual environment may be just as effective of a setting as the classroom for problem-based learning. 

The three-day event is now in its second year. Each day will feature late-breaking clinical trials focused on a different heart valve.

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

See What’s New:

Radiology advocates on Monday said they were "deeply disappointed" with the decision while emphasizing it is still early in the process. 

UPDATED: “These high numbers highlight the disconnect between the two sides as they debate what constitutes a reasonable payment for OON services,” experts write in Health Affairs. 

IR is the fastest growing specialty in California, with demand at 1.5 to 2 times the national average, according to new data from analytics firm Axuall. 

On Monday a district judge in Massachusetts declared the Trump administration’s squashing of billions in NIH grants “void and illegal.”